Key Techniques in Structural Biology, Their Strengths and Limitations
Structural biology uses a variety of techniques to determine the 3D structures of biomolecules such as proteins, nucleic acids and their complexes. In this article, we consider the key techniques, their role in structural biology, strengths and limitations.
Agilent 6495C Triple Quadrupole LC/MS
Most sensitive Agilent LC/TQ delivers confidence into the ppt range and beyond. Reliability to match performance with a 3rd-generation all-metal iFunnel design. Wide mass range of m/z 5-3,000 gives you the flexibility to handle any MRM transition.
World-First Study Identifies Brain Changes Caused by High Blood Pressure
A new study has, for the first time, identified specific brain areas that are damaged by the effects of high blood pressure.
A New Bright Red Fluorescent Protein for the Biologist’s Toolbox
A research team has developed a new bright red fluorescent protein that combines maximum brightness with fast and complete folding.
Actin Strengthens the Effect of Sex Hormones
Steroid hormones act by binding to receptor molecules that switch on and off the activity of hormone-dependent genes. Researchers at the University of Freiburg and Kiel University Hospital have discovered that components of the cytoskeleton are critically involved in this process.
Embracing Data-Driven Modeling Approaches Into Biopharmaceutical Processing
This article explores new workflows using data-driven modeling to improve culture medium and new control algorithms allowing for better modulation within the bioprocess design space.
The Pulse: Psychedelic News From Technology Networks Issue 2
Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.
Passage of the FDA Modernization Act Enables New Era for Preclinical Testing
The 11th-hour passage of The FDA Modernization Act gave a much-needed boost to the advocates of new alternative methods (NAMs) for preclinical testing. In this article, we take a look at why NAMs are needed and what the new legislation means for pharmaceutical companies.
How To Guide
How To Future-Proof Your LIMS: Handling Software Updates
Download this guide to explore types of LIMS upgrades, on-premises installation and SaaS installation.
How To Guide
CRISPR Yeast: Replacing the Need for Plant-Derived Metabolites
Plant-derived compounds are widely used across the pharmaceutical, cosmetics, food and agricultural industries. However, compared to other natural compounds, they often produce a lower yield of secondary metabolites.
High-Throughput Screening in Drug Discovery
Download this listicle to learn more about high-throughput screening, biochemical assays and cell-based assays.
Chemical Analysis in the Petrochemicals Sector
Download this listicle to discover the need for petrochemical analysis and how safety and quality standards are maintained using different analysis techniques.